MARKET

PRAH

PRAH

PRA Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

103.98
-1.18
-1.12%
Opening 14:16 09/18 EDT
OPEN
104.47
PREV CLOSE
105.15
HIGH
104.73
LOW
103.78
VOLUME
120.72K
TURNOVER
--
52 WEEK HIGH
121.98
52 WEEK LOW
82.12
MARKET CAP
6.85B
P/E (TTM)
44.05
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PRAH and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

PRAH News

  • PRA Health Sciences, Symphony Health Launch Metys(TM) National Market Measurement Tool
  • GlobeNewswire.5h ago
  • PRA Health Sciences holders file to offer shares
  • seekingalpha.4d ago
  • UPDATE: KeyBanc On PRA Health Sciences Also Notes 'By our models, PRAH should be able to generate revenue growth of 8%+ and EBITDA growth of 12%+ in 2020 even in the face of some integration headwinds at Symphony Health'
  • Benzinga.5d ago
  • UPDATE: KeyBanc Maintains Overweight On PRA Health Sciences, Announces $118 'after follow-up conversations with management and with the stock trading at a sizable discount'
  • Benzinga.5d ago

More

Industry

Biotechnology & Medical Research
-1.62%
Pharmaceuticals & Medical Research
-0.58%

Hot Stocks

Name
Price
%Change

About PRAH

PRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.
More

Webull offers PRA Health Sciences Inc (PRAH) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.